Washington Post/AP: Biogen Drug Debacle May Drag Down Industry. The debacle over faulty drugs besetting the pharmaceutical industry has now spread to the biotech sector, with one of its best performing companies and a partner pulling their highly touted multiple sclerosis drug from the market after one patient died and another fell seriously ill.
What’s happening? Is this another reality TV show where one drug gets voted off the market each week? I’ve added Biogen Idec contracts to the site. Includes a number of R&D and licensing agreements.